Comparative study of the therapeutic potential of C 24 , C 32 , B 12 N 12 , and B 16 N 16 nanocages as drug delivery carriers for delivering an erlotinib derivative: DFT and QTAIM investigations
Nanoscale · 2025 · 17 (18) · 11413-11425
DOI: 10.1039/d4nr05393a ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Nanoscale, 2025. Verfasst von Khourshid Mehdizadeh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Roudsar and Amlash Branch, Islamic Azad University, Roudsar, Iran. Hauptthemen laut MEDLINE: Erlotinib Hydrochloride, Drug Carriers, Nanostructures. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Ministry of Science, ICT and Future Planning, Ministry of Environment.
Abstract (Originalsprache)
The use of nanostructures as drug delivery vehicles for various anticancer medications represents an innovative biomedical application, reducing severe side effects by enabling targeted delivery to tumor cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Roudsar and Amlash Branch, Islamic Azad University, Roudsar, Iran.
- Department of Chemistry, Science and Research Branch, Islamic Azad University, Tehran, Iran.
- Department of Chemistry, Islamic Azad University, Central Tehran Branch, Tehran, Iran.
- Renewable Energies Research Laboratory, Department of Chemistry, Faculty of Science, University of Sistan and Baluchestan, P.O. Box 98135 674, Zahedan, Iran. farsadroohmajid@gmail.com.
- NanoBio High-Tech Materials Research Center, Department of Biological Sciences and Bioengineering, Inha University, Incheon 22212, Republic of Korea. farani.marzi@inha.ac.kr.
Förderung
- Ministry of Science, ICT and Future Planning
- Ministry of Environment
Zitieren
APA
Mehdizadeh, K., PourFalatoon, S., Nouraliei, M., Farsadrooh, M., Kim, H., Ramezani Farani, M., & Huh, Y. S. (2025). Comparative study of the therapeutic potential of C 24 , C 32 , B 12 N 12 , and B 16 N 16 nanocages as drug delivery carriers for delivering an erlotinib derivative: DFT and QTAIM investigations. Nanoscale, 17(18), 11413-11425. https://doi.org/10.1039/d4nr05393a
Vancouver
Mehdizadeh K, PourFalatoon S, Nouraliei M, Farsadrooh M, Kim H, Ramezani Farani M, et al. Comparative study of the therapeutic potential of C 24 , C 32 , B 12 N 12 , and B 16 N 16 nanocages as drug delivery carriers for delivering an erlotinib derivative: DFT and QTAIM investigations. Nanoscale. 2025;17(18):11413-11425. doi:10.1039/d4nr05393a
BibTeX
@article{Mehdizadeh2025,
author = {Mehdizadeh, Khourshid and PourFalatoon, Sourour and Nouraliei, Milad and Farsadrooh, Majid and Kim, Hanseung and Ramezani Farani, Marzieh and Huh, Yun Suk},
title = {Comparative study of the therapeutic potential of C 24 , C 32 , B 12 N 12 , and B 16 N 16 nanocages as drug delivery carriers for delivering an erlotinib derivative: DFT and QTAIM investigations},
journal = {Nanoscale},
year = {2025},
volume = {17},
number = {18},
pages = {11413--11425},
doi = {10.1039/d4nr05393a}
}
EUVIMED